OrthoSpin wins FDA clearance for its smart Ex-Fix system

By

OrthoSpin Receives FDA Regulatory Clearance (press release)
 OrthoSpin Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its smart, robotic external fixation system for orthopedic treatments.
Today, the use of external fixation is a common treatment option for orthopedic-related problems: bone lengthening, setting complex fractures, and correcting deformities. The two main challenges associated with these systems are...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.